Juvenile Ossifying Fibroma - WHO Type
Journal Title: Journal of Case Reports and Studies - Year 2014, Vol 2, Issue 2
Abstract
Juvenile ossifying fibroma is an uncommon clinical entity, its aggressive local behaviour and high recurrence rate mean that it is important to make an early diagnosis, apply the appropriate treatment and, especially, follow the patient up over the long term. In the current article we report a case of juvenile ossifying fibroma-WHO type in 12yr old patient which was clinical and histopathologically challenging as it was asymptomatic and at an unusual location.
Authors and Affiliations
Rathore AS
Keywords
Related Articles
- EP ID EP582456
- DOI 10.15744/2348-9820.1.502
- Views 123
- Downloads 0
Case Reports and Studies
Welcome to the first issue of the Journal of Case Reports and Studies. Within the field of medicine a number of systems have been established to stratify the quality of research designs which have been collectively terme...
Refractory Hypotension Caused By Prone Position in a Child Undergoing Scoliosis Corrective Surgery
We report a case of a teenager with scoliosis and pectus excavatum who developed intraoperative refractory hypotension associated with prone position during posterior surgical correction of scoliosis. In this case, it wa...
Judging Credibility of a Road Traffic Accident Claimant
The ‘holy grail’ of being able to assess reliability and truthfulness is investigated one step further via this case study utilising a credibility checklist with a road traffic accident claimant. The possibility of opera...
Pediatric Patient with a Celiac Crisis (Rare Presentation of a Common Disease) Case Report and Literature Review
Celiac disease (CD) is a systemic chronic immune-mediated disorder that is associated with weight loss, diarrhea, and laboratory abnormalities. Celiac disease (CD) is a disease in which the mucosal lining of the small in...
Development of Severe Hypophosphatemia from Acquired Fanconi Syndrome during Treatment with Abiraterone
Objectives: To report two cases of patients with metastatic, castration resistant prostate cancer who developed profound hypophosphatemia while on treatment with abiraterone. Case Summary: The first patient was a 77 year...